- increased heart weight / IMPC
- increased blood urea nitrogen level / IMPC
- increased circulating fructosamine level / IMPC
- increased mean corpuscular hemoglobin / IMPC
- decreased circulating calcium level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- increased circulating chloride level / IMPC
- decreased fasting circulating glucose level / IMPC
- increased circulating iron level / IMPC
- decreased circulating glycerol level / IMPC
- decreased circulating cholesterol level / IMPC
C57BL/6NTac-Bhlhe40tm1a(KOMP)Wtsi/WtsiPh
Status | Available to order |
EMMA ID | EM:09819 |
Citation information | RRID:IMSR_EM:09819 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | C57BL/6NTac-Bhlhe40tm1a(KOMP)Wtsi/WtsiPh |
Alternative name | EPD0208_6_A02 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Bhlhe40tm1a(KOMP)Wtsi |
Gene/Transgene symbol | Bhlhe40 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from KOMP ES clone EPD0208_6_A02. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Institute of Molecular Genetics, Prague, Czech Republic |
Disease and phenotype information
IMPC phenotypes (gene matching)
MGI phenotypes (gene matching)
- spleen hyperplasia / MGI
- thymus hyperplasia / MGI
- abnormal immune system cell morphology / MGI
- abnormal immune system physiology / MGI
- abnormal T cell activation / MGI
- altered susceptibility to autoimmune disorder / MGI
- increased IgE level / MGI
- increased susceptibility to pharmacologically induced seizures / MGI
- no phenotypic analysis / MGI
- increased anti-nuclear antigen antibody level / MGI
- increased double-negative T cell number / MGI
- decreased double-positive T cell number / MGI
- decreased T cell proliferation / MGI
- abnormal renal glomerulus morphology / MGI
- abnormal CD4-positive, alpha-beta T cell physiology / MGI
- increased CD4-positive, alpha beta T cell number / MGI
- abnormal CD4-positive T cell differentiation / MGI
- increased CD8-positive, alpha-beta T cell number / MGI
- lymph node hyperplasia / MGI
- increased spleen white pulp amount / MGI
- increased spleen germinal center number / MGI
- increased IgG1 level / MGI
- abnormal lymph node germinal center morphology / MGI
- decreased interleukin-2 secretion / MGI
- delayed circadian behavior phase / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).